ID: ALA165049

Max Phase: Preclinical

Molecular Formula: C24H29F3N2O

Molecular Weight: 418.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1ccc([C@@H]2Cc3c(cccc3C(F)(F)F)N(CCN(C)C)C(=O)[C@@H]2C)cc1

Standard InChI:  InChI=1S/C24H29F3N2O/c1-5-17-9-11-18(12-10-17)19-15-20-21(24(25,26)27)7-6-8-22(20)29(14-13-28(3)4)23(30)16(19)2/h6-12,16,19H,5,13-15H2,1-4H3/t16-,19-/m1/s1

Standard InChI Key:  MQZVQWKSGFGCNS-VQIMIIECSA-N

Associated Targets(Human)

CACNA1S Tclin Voltage-gated L-type calcium channel alpha-1S subunit (46 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cacna1c Voltage-gated L-type calcium channel (1164 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 418.50Molecular Weight (Monoisotopic): 418.2232AlogP: 5.14#Rotatable Bonds: 5
Polar Surface Area: 23.55Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.19CX LogP: 5.64CX LogD: 4.79
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.67Np Likeness Score: -0.54

References

1. Kimball SD, Floyd DM, Das J, Hunt JT, Krapcho J, Rovnyak G, Duff KJ, Lee VG, Moquin RV, Turk CF..  (1992)  Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.,  35  (4): [PMID:1311765] [10.1021/jm00082a020]

Source